Pharmacopeia
CWP-0127
IDARUCIZUMAB
Haematology · Haematology · Level 3
Core pharmacology
- Class Group
Anticoagulant Reversal Agents
- Legacy Cicm Level
Level 3
- Introduction
Monoclonal antibody Fab fragment
- Presentation
IV 5g bolus
- Mechanism of action
Direct binding to Dabigitran
- Adverse Effects Toxicity
Minimal
Headache- Absorption
IV only
- Volume of distribution
Vd 9L
- Metabolism
Hepatic metabolism
- Half-life
T1/2= 1 hour (occasionally require second dose)